Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Editorial: IgA nephropathy: a nephrologist's challenge in 2023.
Catapano F, Flossmann O, Del Vecchio L. Catapano F, et al. Among authors: flossmann o. Front Nephrol. 2024 Sep 11;4:1477350. doi: 10.3389/fneph.2024.1477350. eCollection 2024. Front Nephrol. 2024. PMID: 39323970 Free PMC article. No abstract available.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial.
Odler B, Riedl R, Geetha D, Szpirt WM, Hawley C, Uchida L, Wallace ZS, Walters G, Muso E, Tesar V, Pusey CD, Little MA, Merkel PA, Walsh M, Jayne DRW, Kronbichler A; PEXIVAS Investigators. Odler B, et al. Kidney Int. 2024 Dec 19:S0085-2538(24)00911-6. doi: 10.1016/j.kint.2024.11.029. Online ahead of print. Kidney Int. 2024. PMID: 39708998 Free article.
Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhage.
Chalkia A, Flossmann O, Jones R, Nair JR, Simpson T, Smith R, Willcocks L, Jayne D. Chalkia A, et al. Among authors: flossmann o. Nephrol Dial Transplant. 2024 Aug 30;39(9):1473-1482. doi: 10.1093/ndt/gfae020. Nephrol Dial Transplant. 2024. PMID: 38268434 Free PMC article.
Long-term outcome of kidney function in patients with ANCA-associated vasculitis.
Sachez-Alamo B, Moi L, Bajema I, Berden A, Flossmann O, Hruskova Z, Jayne D, Wester-Trejo M, Wallquist C, Westman K. Sachez-Alamo B, et al. Among authors: flossmann o. Nephrol Dial Transplant. 2024 Aug 30;39(9):1483-1493. doi: 10.1093/ndt/gfae018. Nephrol Dial Transplant. 2024. PMID: 38268409 Free PMC article.
84 results